Author:
Wahi Kanu,Kodar Kristel,McConnell Melanie J.,Harper Jacquie L.,Timmer Mattie S. M.,Stocker Bridget L.
Funder
Cancer Society of New Zealand
Health Research Council of New Zealand
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference43 articles.
1. Temizoz, B., E. Kuroda, and K.J. Ishii. 2016. Vaccine adjuvants as potential cancer immunotherapeutics. International Immunology 28: 329–338.
2. Bowen, W.J., K.S. Abhishek, L. Batra, H. Barsoumian, and H. Shirwan. 2018. Current challenges for cancer vaccine adjuvant development. Expert Review of Vaccines 17: 207–215.
3. Pasquale, A.D., S. Preiss, F.T. Da Silva, and N. Garcon. 2015. Vaccine adjuvants: From 1920 to 2015 and beyond. Vaccines 3: 320–343.
4. Zepp, F. 2016. Principles of vaccination. Methods in Molecular Biology 1403: 57–84.
5. van Ravenswaay Claasen, H.H., P.M. Kluin, and G.J. Fleuren. 1992. Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Laboratory Investigation 67: 166–174.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献